Age: 71.0
Sex: F
Vaccine: FLUX
Symptoms: Blood pressure increased, Computerised tomogram, Headache, Hypertension, Pain
Clinical narrative: Both temples were piercing, headache, entire jaw; Both temples were piercing, headache, entire jaw; Blood pressure 260/180, 230/150; Little achy; This spontaneous case was received on 03-Nov-2021 from other non-health professional (consumer) via Agency (reference number: SEQW21-05032) and concerned a 71-year old female patient. The patient medical history included borderline hyperlipidemia, arthritis, systemic mastocytosis and diabetes. The patient concomitant medications were not provided. The patient's historical vaccines included all three Moderna vaccines (Covid-19 vaccine). The patient waited four weeks after the last booster.   On 28-Oct-2021, the patient was vaccinated with influenza virus vaccine polyvalent (brand not specified; dose, route of administration and anatomical location: not reported) as prevention of seasonal influenza. The batch number was not reported. The patient was not aware which of the Seqirus vaccines she had been administered, but it was one of the quadrivalents.   On 29-Oct-2021 and 30-Oct-2021, after receiving influenza virus vaccine polyvalent, the patient was little achy.   On 30-Oct-2021, the patient recovered from 'ache'.   On 31-Oct-2021, in the morning, the patient's blood pressure was 136/72. Later, the patient's both temples were piercing and entire jaw. The patient experienced headache and blood pressure in the afternoon was 260/180. The patient went to emergency room and was hospitalised. The blood pressure while presenting to the emergency room was 230/150. The patient was on a drip to get blood pressure down over night. While hospitalized, the patient was given Hydralazine (hydralazine hydrochloride) as treatment, and computed tomography (CT) scan was performed, but results were not reported.  On 02-Nov-2021, the patient was discharged from the hospital.  At the time of initial reporting, the patient was recovering from the events of hypertension and headache, reported as subsided.   The outcome of 'jaw pain' was not reported.   The patient did not provide causality assessment. The patient was not sure if the events were related to Moderna Covid-19 vaccine or influenza virus vaccine.    The events of 'hypertension', 'headache' and 'jaw pain' were considered as serious due to hospitalisation.  Company comment: A 71-year-old patient experienced hypertension, jaw pain, headache, and ache within three days after receiving influenza virus vaccine polyvalent. The patient concomitant drugs were not provided. Although advance age of patient, systemic mastocytosis and diabetes contributed to the development of the events, causality is assessed as possibly related, due to compatible time relationship.; Sender's Comments: A 71-year-old patient experienced hypertension, jaw pain, headache, and ache within three days after receiving influenza virus vaccine polyvalent. The patient concomitant drugs were not provided. Although advance age of patient, systemic mastocytosis and diabetes contributed to the development of the events, causality is assessed as possibly related, due to compatible time relationship.